The new guidelines include both “strong” recommendations, which are generally supported by moderate or high-quality evidence, and “conditional” recommendations, which are generally supported by lower-quality evidence.

Although lupus survival has improved throughout the years, presenters in the Monday session Lupus Treatment: B Cells, Interferon & More emphasized that a serious need remains for new treatments and better trial designs.

Showcasing cutting-edge rheumatology research from around the world, six of the top abstracts submitted for this year’s Annual Meeting were presented during Monday’s Plenary II session.

The FDA approved the first treatment for pediatric patients with lupus, among other products and drugs for new indications and populations, and made several important safety updates in 2019, which were reviewed during an Annual Meeting session on Monday.

It’s a time of exciting new treatment discoveries and improved patient outcomes, but it should come as no surprise to rheumatologists that adult rheumatology workforce projections look grim.

Evidence-based treatment guidelines for OA inform clinicians about proper management of this common chronic condition, but studies show those recommendations aren’t being implemented effectively in real-world clinical settings.

Social media use — and misuse — continues to increase, so a Monday morning session at the ACR/ARP Annual Meeting focused on how medical professionals can successfully navigate the digital world.

There is growing recognition that key events in autoimmune disease onset and amplification occur in lymphoid and target tissues affected by the disease process, and a Tuesday morning session will feature state of-the-art data on novel investigative approaches.

Electronic documentation was designed to streamline practices and save clinicians time and money. If the system used in your practice isn’t, then Tuesday’s Business Administration session How to Make the EMR Work for You may be able to provide some practical tips and tricks.

According to data published in Arthritis & Rheumatology, and a recent ACR workforce analysis highlighting a lack of rheumatology care in rural areas, the need for telehealth access may be greater than ever.